Our team of scientists is dedicated to pushing the boundaries of research and innovation.
Yan Lavrovsky, CEO and CSO
Previously, Yan held executive positions at several companies in San Diego, California; Boston, Massachusetts; and Geneva, Switzerland. Yan is a trained physician with a Ph.D. in Molecular Biology. He completed his post-doctoral training at the Rockefeller University in New York and was a faculty member at the University of Texas Health Science Center for six years. Yan is the author of more than 60 original research articles, reviews, and patents.
Gabriela Stevens, HR and Finance Specialist
For the past 25 years, Gabriela Stevens has held various roles in Human Resources and Finance, specializing in fund management. She takes pride in fostering a thriving workplace culture with a people-first mindset and is committed to enhancing organizational performance through strategic financial planning.
Sergei Barbashov, Senior Director of Protein Therapeutics
Dr. Barbashov is a biotechnology professional specializing in downstream process development of biotherapeutics, formulation, analytical methods, and viral clearance studies. After receiving his PhD degree, Sergei worked at Science and Technology Agency in Japan as an invited scientist. Then, Sergei dedicated 7 years to Harvard Medical School as a researcher and Instructor in Medicine. Later, he spent over 20 years working at different biotech companies in Massachusetts, Illinois, and California, where he led purification and characterization of therapeutic proteins and peptides. Sergei has numerous scientific publications.
Scott Eberhardy, Principal Scientist
Scott has 20 years of experience in cell and molecular biology in the pharmaceutical industry developing and optimizing mammalian cell lines that produce recombinant proteins.
Scott previously worked at biotech and pharmaceutical companies (Merck, Amgen, Kerry) where his primary duties were to work with mammalian cell lines such as CHO and HEK293 to produce recombinant proteins such as monoclonal antibodies for research and clinical applications. In addition, he had worked at the CROs Aragen Bioscience and Goodwin Biotechnology, where he collaborated with clients to improve processes for maximized protein production in stable mammalian cell lines.
Scott received a Bachelor of Science in Molecular Biology and a Ph.D. in Cellular and Molecular Biology from the University of Wisconsin-Madison.
Benjamin Saylor, Senior Scientist
Originally from Northern California, Benjamin Saylor came to San Diego to study biochemistry and molecular biology at San Diego State University and UC San Diego. As a PhD candidate, he studied protein science and enzymology. As a postdoctoral scholar at the UC San Diego School of Medicine, he investigated protein structure-function relationships in human inflammatory pathways, identifying the structural basis for a protein-protein interaction implicated in anti-inflammatory lipid metabolism. He has been working in the biopharmaceutical sector for four years, developing purification processes for IgG and IgG-like therapeutics. He specializes in protein purification and analytics.
Andrew Burns, Associate Scientist
Experienced professional with 30 years experience in the Biotech/Pharmacetical industry. 5 years in Lyme disease diagnostic kit manufacture, 22 years experience in Monoclonal antibody production and over 3 years in Biologics process development.
Has also served as Industry Instructor at San Diego City College. Has worn a wide range of hats-everything from Validation to Project lead while maintaining a high level of productivity.